142 related articles for article (PubMed ID: 35894946)
1. Designing ferritin nanocage based vaccine candidates for SARS-CoV-2 by
Manickavasagam P; Abhishek S; Rajakumara E
J Biomol Struct Dyn; 2023; 41(13):6121-6133. PubMed ID: 35894946
[TBL] [Abstract][Full Text] [Related]
2. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
[TBL] [Abstract][Full Text] [Related]
3. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants.
Ezzemani W; Kettani A; Sappati S; Kondaka K; El Ossmani H; Tsukiyama-Kohara K; Altawalah H; Saile R; Kohara M; Benjelloun S; Ezzikouri S
J Biomol Struct Dyn; 2023 Jul; 41(11):4917-4938. PubMed ID: 35549819
[TBL] [Abstract][Full Text] [Related]
4. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
[TBL] [Abstract][Full Text] [Related]
5. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
Jyotisha ; Singh S; Qureshi IA
J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
[TBL] [Abstract][Full Text] [Related]
6. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
7. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
[TBL] [Abstract][Full Text] [Related]
8.
Devi A; Chaitanya NSN
J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
[TBL] [Abstract][Full Text] [Related]
9. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
10. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
11.
Bayani F; Safaei Hashkavaei N; Karamian MR; Uskoković V; Sefidbakht Y
J Biomol Struct Dyn; 2023; 41(21):11748-11762. PubMed ID: 36703619
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches.
Marriam S; Afghan MS; Nadeem M; Sajid M; Ahsan M; Basit A; Wajid M; Sabri S; Sajid M; Zafar I; Rashid S; Sehgal SA; Alkhalifah DHM; Hozzein WN; Chen KT; Sharma R
Front Cell Infect Microbiol; 2023; 13():1134802. PubMed ID: 37293206
[TBL] [Abstract][Full Text] [Related]
13. Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches.
Abbasi BA; Saraf D; Sharma T; Sinha R; Singh S; Sood S; Gupta P; Gupta A; Mishra K; Kumari P; Rawal K
PeerJ; 2022; 10():e13380. PubMed ID: 35611169
[TBL] [Abstract][Full Text] [Related]
14. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
15. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an
Enayatkhani M; Hasaniazad M; Faezi S; Gouklani H; Davoodian P; Ahmadi N; Einakian MA; Karmostaji A; Ahmadi K
J Biomol Struct Dyn; 2021 May; 39(8):2857-2872. PubMed ID: 32295479
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccination.
Khan MS; Khan IM; Ahmad SU; Rahman I; Khan MZ; Khan MSZ; Abbas Z; Noreen S; Liu Y
Front Immunol; 2022; 13():1001430. PubMed ID: 36685569
[TBL] [Abstract][Full Text] [Related]
17. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
Sanami S; Alizadeh M; Nosrati M; Dehkordi KA; Azadegan-Dehkordi F; Tahmasebian S; Nosrati H; Arjmand MH; Ghasemi-Dehnoo M; Rafiei A; Bagheri N
Comput Biol Med; 2021 Jun; 133():104390. PubMed ID: 33895459
[TBL] [Abstract][Full Text] [Related]
18. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
19. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
20. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage.
Shukla P; Pandey P; Prasad B; Robinson T; Purohit R; D'Cruz LG; Tambuwala MM; Mutreja A; Harkin J; Rai TS; Murray EK; Gibson DS; Bjourson AJ
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34962259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
